Zhiqiang Ning
University of Science and Technology of China(CN)Chinese Academy of Sciences(CN)Hefei Institutes of Physical Science(CN)
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Peroxisome Proliferator-Activated Receptors, Protein Degradation and Inhibitors, Diabetes Treatment and Management, Immune Cell Function and Interaction
Most-Cited Works
- → Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts(2017)357 cited
- → Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity(2011)287 cited
- → Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial(2019)264 cited
- → Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China(2016)164 cited
- → Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas(2012)122 cited
- → Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up‐regulate transcription of adiponectin